Exactech Trustee Sues TPG, Alleging Concealment of Device Defects to Avoid Liability
Event summary
- Exactech Trustee filed a lawsuit in Delaware Court of Chancery on February 5, 2026, against TPG Inc., alleging concealment of orthopedic implant defects and delayed recalls.
- TPG, which acquired Exactech in 2018, is accused of prioritizing investment preservation over patient safety, pushing the company into Chapter 11 bankruptcy.
- Thousands of injured patients, now unsecured creditors, face significant medical and financial harm due to recalled Exactech devices.
- Parker Waichman LLP supports the lawsuit, representing multiple personal-injury claimants affected by defective Exactech implants.
The big picture
The lawsuit highlights the tension between private equity investment strategies and patient safety in the medical device industry. TPG's alleged actions underscore broader concerns about corporate accountability and the prioritization of financial returns over regulatory compliance. The case could set a precedent for how private equity firms manage acquisitions in highly regulated sectors.
What we're watching
- Governance Dynamics
- How TPG's alleged control over Exactech's board and management will influence the outcome of the lawsuit and future corporate governance practices.
- Regulatory Headwinds
- Whether this case will prompt stricter regulatory oversight of private equity firms in the medical device sector.
- Execution Risk
- The pace at which the Delaware Court of Chancery will adjudicate the claims and the potential impact on unsecured creditors.
Our editorial coverage:
Related topics